opfweek.blogg.se

The principal executive offices of the Issuer are located at 156 West 56th Street, Suite 2001, New York, Relates is the common stock, $.01 par value per share (the “Shares”), of NWH, Inc., a Delaware corporation (the “Issuer”). The class of equity securities to which this statement on Schedule 13D (this “Schedule 13D”) Wholly-owned subsidiary of UnitedHealth Group Incorporated.

The number of shares reported as being beneficially owned by UnitedHealth Group Incorporated are calculated based on the number of shares held by stockholders of the Issuer that are party to Voting Agreements with Ingenix, Inc., a UnitedHealth Group Incorporated disclaims beneficial ownership of such shares and this statement shall not be construed as an admission that UnitedHealth Group Incorporated is the beneficial owner of any securities covered by this The Issuer’s Form 8-K filed with the Securities and Exchange Commission on May 26, 2006. are calculated based on the number of shares held by stockholders of the Issuer that are party to Voting Agreements with Ingenix, Inc., which is a wholly-owned subsidiary of UnitedHealth Groupīased upon an aggregate of 2,910,859 shares of common stock outstanding as of the close of business on May 25, 2006, as set forth in the Agreement and Plan of Merger attached hereto as Exhibit 4 and previously filed as Exhibit 2.1 to

Reported as being beneficially owned by Ingenix, Inc. is the beneficial owner of any securities covered by this statement. disclaims beneficial ownership of such shares and this statement shall not be construed as an admission that Ingenix, Inc. TYPE OF REPORTING PERSON (See Instructions) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) OF ABOVE PERSONS:ĬHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)ĬHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)ĪGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSONĬHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) Subject of this Schedule 13D, and is filing this schedule because of Secs. If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

Under the Securities Exchange Act of 1934